HZHong Zhao

Hong Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hong Zhao has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Junkang Zhao

    Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi Province, China

    2 shared publications
  • Liyun Zhang

    Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China

    2 shared publications
  • Yangyu Xu

    Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi Province, China

    2 shared publications
  • Yuxiang Gao

    Rheumatology and Immunology Department, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, Shanxi, China

    2 shared publications
  • Jiannan Han

    Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Tongji Shanxi Hospital Taiyuan 030032 China

    1 shared publication
  • Jiannan Han

    Rheumatology and Immunology Department, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, Shanxi, China

    1 shared publication

Latest Publications

  • Open Access

    Association Between Neutrophil Percentage–Albumin Ratio and Biological Aging in Rheumatoid Arthritis in the United States: A Cross‐Sectional Study of NHANES

    by Yangyu Xu, Hong Zhao, Yuxiang Gao, Li Zhao, Jiannan Han, Rong Li, Zewen Wu, Junkang Zhao, Liyun Zhang

    Background: The accelerating process of global aging has made the burden of age‐related diseases increasingly severe, and traditional chronological age fails to reflect individual heterogeneity in aging. The neutrophil percentage‐to‐albumin ratio (NPAR), is a multidimensional health assessment index composed of inflammatory markers (neutrophils) and nutritional markers (albumin) to reflect inflammation and nutritional status, has shown unique potential in rheumatoid arthritis (RA) research. However, its association with biological age (BA; such as Klemera–Doubal method [KDM] age and phenotypic age, PhenoAge) has not yet been systematically validated in RA patients. By evaluating NPAR indicators in patients with RA, this study intends to reveal its value as a potential biomarker for predicting biological aging and its acceleration. Methods: This study was based on the National Health and Nutrition Survey 1999–2018 cycle database, and a cross‐sectional analysis of 1053 adult patients with RA was included. Core variable definitions include: neutrophil–albumin ratio (NPAR) = percentage of neutrophils (%)/albumin (g/dL); BA was calculated by the KDM (including 10 biomarkers) and the PhenoAge algorithm, respectively. Accelerated aging is quantified as the difference between BA and chronological age. The statistical analysis used a multi‐model validation strategy: 1) multivariate linear regression to evaluate the association between NPAR and continuous aging acceleration indicators; 2) the restricted cubic spline (RCS) model explores the nonlinear relationship; 3) stratified subgroup analysis to test for effect heterogeneity. All models were stratified for sociodemographic characteristics (age, sex, and ethnicity), lifestyle factors (smoking, alcohol consumption, and physical activity), and clinical covariates (body mass index [BMI], hypertension, and history of diabetes). Results: In an analysis of 1053 RA patients in the United States, women accounted for 56.48% and men for 43.52%; the group with the highest NPAR (T3) showed more significant aging characteristics (≥65 years old 34.75%, females 62.80%, and diabetes 27.69%) and higher biological aging acceleration rates (KDM acceleration 42.81% vs. low group 25.81%; PhenoAge acceleration 62.13% vs. 37.74%; all p < 0.001). After adjustment for multiple factors, the BA of KDM increased by 0.86 years for every 1 unit increase in NPAR (95% confidence interval [CI]: 0.39–1.32, p < 0.001), and PhenoAge increased by 1.32 years (95% CI: 0.93–1.71, p < 0.001). Taking the lowest NPAR group (T1) as the reference group, the highest NPAR group (T3) had an increased risk of accelerated aging of KDM by 149% (OR = 2.49, 95% CI: 1.44–4.31), and the risk of PhenoAge increased sharply by 259% (OR = 3.59, 95% CI: 2.17–5.95). Nonrestrictive spline curve analysis further revealed that there was a nonlinear positive correlation between the NPAR index and biological aging. When NPAR > 13.128, the growth rate of biological aging was significantly accelerated ( p for nonlinear = 0.05), while when NPAR > 14.512, the risk of phenotypic aging accelerated sharply ( p for nonlinear = 0.002). Area under the curve (AUC) of NPAR in the combined model for predicting biological senescence acceleration was 0.71–0.75. Discussion: Elevated NPAR is significantly associated with accelerated biological aging in RA patients, and the mechanism may involve neutrophil migration dysfunction, oxidative damage caused by albumin deficiency, and chronic inflammatory pathways (such as NF‐ κ B activation). As a low‐cost inflammatory marker, NPAR holds promise for integration into clinical aging risk assessment systems to identify high‐risk RA populations requiring early intervention. The study’s limitations include the inability to infer causality due to the cross‐sectional design and a relatively small sample size, necessitating further validation through cohort studies in the future.


  • Open Access

    Investigating the Impact of Gut Microbiota and Immune Cells on Ankylosing Spondylitis From a Genetic Perspective: A Mendelian Randomization and Mediation Study

    by Jiannan Han, Jingying Wu, Hong Zhao, Yangyu Xu, Yuxiang Gao, Jie Kang, Junkang Zhao, Liyun Zhang

    Background: Previous studies have separately reported causal relationships between gut microbiota and ankylosing spondylitis (AS), as well as between immune cells and AS. However, the potential causal relationships between gut microbiota/immune cells and AS have not been explored. In this study, we elucidated the role of gut microbiota in the progression of AS through the regulation of immune cells. Methods: Inverse‐variance weighted (IVW) was used as the primary analysis method, supplemented by MR‒Egger, simple mode, weighted median, and weighted mode methods to determine the causal relationships between gut microbiota and AS. Additionally, Bayesian weighted Mendelian randomization (BWMR) was used to identify the strongest causal associations, and mediation MR analysis was performed to explore the potential mediating role of immune cells in the relationship between gut microbiota and AS. Results: MR analysis identified 13 microbial taxa significantly associated with AS, of which eight were significantly associated with an increased risk of AS. Additionally, five microbial taxa were significantly associated with a reduced risk of AS. Furthermore, 19 immunophenotypes were significantly associated with AS, of which 11 were linked to an increased risk of AS. Additionally, eight immune cells were associated with a reduced risk of AS. Mediation MR analysis revealed that two immune cells mediated the causal relationships of two gut microbiota: CX3CR1 on monocyte mediated a 7.91% increase in AS risk through the CAG‐83 sp000435555 abundance in stool pathway, and CD45 on CD33 − HLA DR − mediated a 12.04% increase in AS risk through the Clostridium S felsineum abundance in stool pathway. Multiple sensitivity analyses confirmed the robustness of our results. Conclusion: This study is the first to reveal the causal relationships among gut microbiota, immune cells, and AS. These findings provide genetic evidence supporting a potential causal role of gut microbiota in AS, suggesting that immune cells may act as mediators.